Skip to content

Drug interactions

Natalizumab + Ofatumumab sc

Severity: Major

Natalizumab and Ofatumumab sc: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs affect immune surveillance, and combined use may increase the risk of serious infection, including PML. Ofatumumab depletes B cells while natalizumab restricts lymphocyte entry into tissues such as the CNS.

What this interaction means in plain words

Natalizumab and Ofatumumab sc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive immunosuppression via B-cell depletion and inhibition of leukocyte trafficking.

What to do

Avoid concurrent use. When switching, consider the prolonged effects of the previous agent and monitor for infection and neurological changes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Natalizumab and Ofatumumab sc, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Natalizumab with Ofatumumab sc?

MediHelp rates the interaction as major. Natalizumab and Ofatumumab sc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs affect immune surveillance, and combined use may increase the risk of serious infection, including PML. Ofatumumab depletes B cells while natalizumab restricts lymphocyte entry into tissues such as the CNS.

How serious is the interaction between Natalizumab and Ofatumumab sc?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use. When switching, consider the prolonged effects of the previous agent and monitor for infection and neurological changes.

What other medicines interact with Natalizumab?

MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Baricitinib. The full list is on the Natalizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in